TCL065
TCL065 is an ionizable lipid with a pKa of 6.3. TCL065 can be used to generate lipid nanoparticles (LNPs) for the delivery of mRNA as well as single-guide RNA (sgRNA) both in vitro and in vivo. TCL065-containing LNPs can studied in research for Duchenne muscular dystrophy and gene-editing technologies[1].
Product Specifications
CAS Number
1872269-57-2
UNSPSC
12352211
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease; Inflammation/Immunology
Smiles
O=C(CCCCN(C)C)OCC(COC(CC(CCCCC)CCCCC)=O)(COC(CC(CCCCC)CCCCC)=O)COC(CC(CCCCC)CCCCC)=O
Molecular Formula
C51H97NO8
Molecular Weight
852.32
References & Citations
[1]Kenjo, E., et al., (2021) . Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice. Nature communications, 12 (1), 7101.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A01813-3-HRP 100 µg/Vial
Anti-Kv1.1 potassium channel/KCNA1 Antibody Picoband®, HRP Conjugate
Sign In for Pricing
View Details 
bsm-62604R-PerCP-TR 20 µL
TRAPPC2 Recombinant Antibody, PerCP Conjugated
Sign In for Pricing
View Details GTR15132225 1 Vial
Lentiviral mouse Neurod1 shRNA (UAS) - Lentiviral mouse Neurod1 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
038358 200 µL
MEPCE, ID (MEPCE, BCDIN3, 7SK snRNA methylphosphate capping enzyme, Bicoid-interacting protein 3 homolog)
Sign In for Pricing
View Details